Access Statistics for Bonny Parkinson

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Measuring the loss of consumer choice in mandatory health programs using Discrete Choice Experiments. CHERE Working Paper 2012/04 0 0 0 0 0 2 5 74
Pharmaceutical policy in Australia. CHERE Working Paper 2013/01 0 0 1 74 0 3 8 197
Total Working Papers 0 0 1 74 0 5 13 271


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
An examination of machine learning to map non‐preference based patient reported outcome measures to health state utility values 0 0 0 1 1 4 10 22
Authors’ Reply to Palozzo and Messori: ‘‘Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review’’ 0 0 0 2 0 1 1 18
Bring Out Your Dead: A Review of the Cost Minimisation Approach in Health Technology Assessment Submissions to the Australian Pharmaceutical Benefits Advisory Committee 0 0 0 0 0 3 9 11
Considering consumer choice in the economic evaluation of mandatory health programmes: A review 0 0 0 5 0 2 4 65
Correction to: Economic Evaluations of Childhood Hearing Loss Screening Programmes: A Systematic Review and Critique 0 0 0 3 0 0 1 23
Cost-Effectiveness Analysis of Prostate-Specific Membrane Antigen (PSMA) Positron Emission Tomography/Computed Tomography (PET/CT) for the Primary Staging of Prostate Cancer in Australia 0 0 0 0 1 5 7 18
Disinvestment and Value-Based Purchasing Strategies for Pharmaceuticals: An International Review 0 0 0 2 0 5 8 70
Economic Evaluations of Childhood Hearing Loss Screening Programmes: A Systematic Review and Critique 0 0 0 2 1 6 9 37
Economic evaluations of trastuzumab in HER2-positive metastatic breast cancer: a systematic review and critique 0 0 0 9 1 2 2 48
Integrating Health Economics Into the Product Development Cycle 0 0 0 0 0 4 6 10
Is Reclassification of the Oral Contraceptive Pill from Prescription to Pharmacist-Only Cost Effective? Application of an Economic Evaluation Approach to Regulatory Decisions 0 0 0 2 0 1 2 18
Lifetime health costs of intimate partner violence: A prospective longitudinal cohort study with linked data for out-of-hospital and pharmaceutical costs 0 1 3 7 0 3 12 35
Mapping the Patient-Reported Outcomes Measurement Information System (PROMIS-29) to EQ-5D-5L 0 0 0 0 1 4 9 15
Measuring the Loss of Consumer Choice in Mandatory Health Programmes Using Discrete Choice Experiments 0 0 0 6 0 3 6 45
Real-World Evidence: A Comparison of the Australian Herceptin Program and Clinical Trials of Trastuzumab for HER2-Positive Metastatic Breast Cancer 0 0 0 1 1 4 6 27
The Real-World Cost-Effectiveness of Coronary Artery Bypass Surgery Versus Stenting in High-Risk Patients: Propensity Score-Matched Analysis of a Single-Centre Experience 0 0 0 2 0 2 6 37
The cost-effectiveness of unilateral cochlear implants in UK adults 0 0 0 0 0 2 2 7
Unravelling the Association Between Uncertainties in Model-based Economic Analysis and Funding Recommendations of Medicines in Australia 0 0 0 0 0 5 15 25
Total Journal Articles 0 1 3 42 6 56 115 531


Statistics updated 2026-03-04